Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients

Table 1 Baseline demographics of the 207 patients

Characteristics	Value
Gender (male, %)	118 (57%)
Age of HBeAg seroconversion (yr)	40 (34-45)1
Follow-up duration (yr)	13.1 (11.8-15.5)1
Liver biochemistry
Bilirubin (μmoL/L)	12 (9-16)1
ALP (U/L)	69 (57-82)1
AST (U/L)	29 (23-37)1
ALT (U/L)	32 (21-50)1
GGT (U/L)	23 (16-36)1
Albumin (g/dL)	43 (41-45)1
Globulin	34 (31-36)1
AFP (ng/mL)	4 (3-7)1
HBV DNA (log IU/mL)	4 (3-5.4)1
Baseline M2BPGi	0.42 (0.27-0.68)1

¹Median and values in brackets represented interquartile range. AFP: Alpha feto protein; ALP: Alkaline phosphatase; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma glutamyl transferase; HBV: Hepatitis B virus; HBeAg: Hepatitis B e antigen; M2BPGi: Mac-2 binding protein glycosylation isomer.